A new manufacturing site of German company BioNTech for the production of Covid-19 vaccine is pictured on January 12, 2021 in Marburg, central Germany. - BioNTech, which developed the first coronavirus vaccine approved in the West, expects to produce two billion doses in 2021, up from the 1.3 billion previously forecast. The Mainz-based company, which developed the jab with US giant Pfizer, is planning to open its new factory in Marburg in February, expected to ramp up production capacity by 750 million doses a year. The site will join five other sites in Germany, Belgium and the US shared with Pfizer. (Photo by Thomas Lohnes / AFP)